| Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion | Science | 2011 | 3.8K |
| Natural innate and adaptive immunity to cancer | Annual Review of Immunology | 2011 | 1.4K |
| Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists | Modern Pathology | 2011 | 447 |
| Does lung adenocarcinoma subtype predict patient survival?: A clinicopathologic study based on the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society international multidisciplinary lung adenocarcinoma classification | Journal of Thoracic Oncology | 2011 | 411 |
| Anti-ErbB-2 mAb therapy requires type I and II interferons and synergizes with anti-PD-1 or anti-CD137 mAb therapy | Proceedings of the National Academy of Sciences of the United States of America | 2011 | 334 |
| Clinical outcome and pathological features associated with NRAS mutation in cutaneous melanoma | Pigment Cell and Melanoma Research | 2011 | 168 |
| Deregulation of MYCN, LIN28B and LET7 in a molecular subtype of aggressive high-grade serous ovarian cancers | PLoS ONE | 2011 | 143 |
| DOCK8 deficiency impairs CD8 T cell survival and function in humans and mice | Journal of Experimental Medicine | 2011 | 140 |
| Recruitment of regulatory T cells is correlated with hypoxia-induced CXCR4 expression, and is associated with poor prognosis in basal-like breast cancers | Breast Cancer Research | 2011 | 124 |
| Constitutional methylation of the BRCA1 promoter is specifically associated with BRCA1 mutation-associated pathology in early-onset breast cancer | Cancer Prevention Research | 2011 | 121 |
| AKT promotes rRNA synthesis and cooperates with c-MYC to stimulate ribosome biogenesis in cancer | Science Signaling | 2011 | 104 |
| Eradication of solid tumors using histone deacetylase inhibitors combined with immune-stimulating antibodies | Proceedings of the National Academy of Sciences of the United States of America | 2011 | 88 |
| Decreased prostate cancer-specific survival of men with BRCA2 mutations from multiple breast cancer families | Cancer Prevention Research | 2011 | 82 |
| Annexin-1 signals mitogen-stimulated breast tumor cell proliferation by activation of the formyl peptide receptors (FPRs) 1 and 2 | FASEB Journal | 2011 | 77 |
| Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium | Human Molecular Genetics | 2011 | 66 |
| IFN-γ production by lung NK cells is critical for the natural resistance to pulmonary metastasis of B16 melanoma in mice | Journal of Leukocyte Biology | 2011 | 65 |
| Enhanced RAD21 cohesin expression confers poor prognosis and resistance to chemotherapy in high grade luminal, basal and HER2 breast cancers | Breast Cancer Research | 2011 | 62 |
| Assessing combined methylation-sensitive high resolution melting and pyrosequencing for the analysis of heterogeneous DNA methylation | Epigenetics | 2011 | 55 |
| Analysing DNA methylation using bisulphite pyrosequencing | Methods in Molecular Biology | 2011 | 53 |
| Inhibition of DNA-dependent protein kinase induces accelerated senescence in irradiated human cancer cells | Molecular Cancer Research | 2011 | 49 |
| Myb controls intestinal stem cell genes and self-renewal | Stem Cells | 2011 | 46 |
| The role of KRAS rs61764370 in invasive epithelial ovarian cancer: implications for clinical testing | Clinical Cancer Research | 2011 | 45 |
| Nuclear and cytoplasmic expressions of ERβ1 and ERβ2 are predictive of response to therapy and alters prognosis in familial breast cancers | Breast Cancer Research and Treatment | 2011 | 44 |
| MYB is essential for mammary tumorigenesis | Cancer Research | 2011 | 44 |
| "Overcoming breast cancer drug resistance with mTOR inhibitors". Could it be a myth or a real possibility in the short-term future? | Breast Cancer Research and Treatment | 2011 | 43 |
